The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| SMMNY | -4.96% | +23.54% | +4.32% | +32% |
| S&P | +14.08% | +93.57% | +14.12% | +151% |
Siemens Healthineers AG operates as a holding company. The company intends to operate the digital services business. It operates through the following business segments: Imaging, Diagnotics, and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on December 1, 2017 and is headquartered in Erlangen, Germany.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $7.39B | 6.3% |
| Gross Profit | $2.77B | 4.9% |
| Gross Margin | 37.55% | -0.5% |
| Market Cap | $60.71B | -9.5% |
| Market Cap / Employee | $0.82M | -11.7% |
| Employees | 73.8K | 2.5% |
| Net Income | $697.62M | 1.8% |
| EBITDA | $1.41B | -18.9% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $2.56B | -14.7% |
| Accounts Receivable | $7.70B | 9.5% |
| Inventory | 4.9K | 4.2% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $13.33B | -11.3% |
| Short Term Debt | $4.07B | 32.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 4.59% | 0.4% |
| Return On Invested Capital | 6.50% | -1.1% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $804.33M | -27.7% |
| Operating Free Cash Flow | $1.12B | -17.0% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 27.60 | 26.73 | 26.19 | 25.46 | -20.18% |
| Price to Book | 2.90 | 2.93 | 3.09 | 2.93 | -14.72% |
| Price to Sales | 2.78 | 2.44 | 2.43 | 2.45 | -9.39% |
| Price to Tangible Book Value | -8.09 | -9.54 | -8.87 | -8.45 | -3.43% |
| Price to Free Cash Flow TTM | 87.78 | 42.74 | 236.16 | 37.05 | -92.32% |
| Enterprise Value to EBITDA | 74.78 | 58.43 | 54.01 | 55.16 | 19.51% |
| Free Cash Flow Yield | 1.1% | 2.3% | 0.4% | 2.7% | 1202.58% |
| Return on Equity | 10.7% | 11.1% | 11.8% | 11.5% | 7.25% |
| Total Debt | $17.21B | $18.21B | $18.43B | $17.39B | -3.86% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
